Julie Moreno — an assistant professor in CSU's Department of Environmental and Radiological Health Sciences — examines the mechanisms that prompt neurons and other brain cells to become inflamed, leading to Alzheimer’s disease and other dementias.

Here we discuss the processes that happen in the brain throughout neurodegeneration and what Moreno’s lab is doing to test potential therapies to slow down neurodegeneration. We also discuss a new drug for the treatment of Alzheimer's, called Aduhelm (Aducanumab), that was approved by the FDA in early June: what it is and why there’s a debate surrounding it.